Who It Is For First-time peptide therapy patients looking for a proven, well-tolerated starting point Adults over 35 experiencing declining energy, poor sleep, slower recovery, or gradual body composition changes Patients who want to optimize growth hormone naturally without exogenous GH Athletes seeking improved recovery and training adaptation Anyone building a foundation before adding more targeted peptides What to Expect Weeks 1-2: Improved sleep quality is typically the first noticeable change
Fly strains UAS-GFP (Bloomington Stock #6874), TH-Gal4 (Bloomington Stock #8848), CatalaseRNAi (Bloomington Stock #34020) and PHGPx (Bloomington Stock #33939), were obtained from Bloomington stock center, Indiana, along with park 13 (Bloomington Stock #79210) as the Parkinsonian disease model
Is it FDA-approved
After linking gut redox and the microbiome 10 , this is the first study linking major antioxidants in the human body, gut microbiome and health through butyrate production
The Verdict: Interesting but inconclusive
2025, doi: 10.1016/j.ajcnut.2025.04.023